The Curis Lifesciences Ltd IPO price band is fixed between ₹120 and ₹128 per share, with a face value of ₹10 per equity share. Investors can bid for a minimum of 1,000 shares (1 lot) and in multiples of 1,000 shares thereafter.
At the upper band of ₹128, one lot amounts to an investment of ₹1,28,000, offering investors an affordable entry into India’s rapidly expanding pharmaceutical manufacturing and R&D ecosystem.
The well-defined lot structure ensures inclusive participation — from retail investors seeking exposure to the healthcare sector’s resilience to institutional players betting on the company’s research-driven growth potential.